IDSA agrees to re-examine chronic Lyme disease guidelines McKesson to pay $13 million-plus for failure to report suspicious sales Some criticism drawn over FDA authority bill FDA issues approvable letter for Surfaxin NACDS Foundation announces election results Young joins Perrigo as pharmacovigilance manager Pfizer initiates settlements of its painkiller cases Vertex reports positive results for telaprevir against hep C Walgreens announces internal exec shifts Watson submits application to FDA for generic Fentora First Previous 2510 2511 2512 2513 2514 Next Last
